Grant: SELECTA BIOSCIENCES, INC.
Primary Recipient
SELECTA BIOSCIENCES, INC.
Amount
$2,996,608.00
Award Date
4/30/2010
Administering Agency
Health and Human Services, Department of / National Institutes of Health
CDFA Number
93.701
CDFA Program Title
Trans-NIH Recovery Act Research Support
Description
The goal of this project is to develop a superior anti-nicotine vaccine for smoking cessation. A high incidence of smoking makes smoking-related diseases the leading cause of preventable death and morbidity. Even though 70% of smokers desire to quit and 4